Democratic lawmakers erupted in condemnation Friday after a three-judge panel on the 5th U.S. Circuit Court of Appeals reinstated in-person requirements for prescribing and dispensing the abortion pill mifepristone, effectively blocking telehealth access and mail delivery of the medication nationwide. The ruling reverses a Biden administration policy that had expanded access during the COVID-19 pandemic.
Representative Ayanna Pressley (D-Mass.) took to social media to blast the decision, calling the panel packed with Trump-appointed extremists who decided to make medication abortion harder to access. She emphasized that mifepristone is safe, effective, and FDA-approved, vowing that Democrats won't stop fighting to protect reproductive freedom and this essential form of healthcare.
The ruling, which stems from a challenge by Louisiana officials who argued that mailing the pills into the state conflicted with its near-total abortion ban, reinstates a 2021 requirement that mifepristone be prescribed and dispensed in person. The drug, approved by the FDA in 2000, is typically used in combination with misoprostol and has been widely prescribed through clinics and, more recently, online providers.
Senator Patty Murray (D-Wash.) wrote on social media that the Fifth Circuit just told millions of women that three judges know better than the FDA, their doctors, and 25 years of evidence. She declared this restriction on medication abortion a nationwide abortion restriction, full stop, and said she has no intention of letting it stand.
Democratic lawmakers warned that the rollback would create new barriers, particularly in rural areas and states where telehealth has become more common. Senator Amy Klobuchar (D-Minn.) said the decision creates new barriers to care and called for restoring women's access to healthcare. Senator Ron Wyden (D-Ore.) echoed that warning, calling the ruling a nationwide abortion ban and accusing Republicans of a calculated plot to control women's private healthcare decisions.
Senator Maria Cantwell (D-Wash.) raised alarms about impacts on states that protect abortion rights, noting that mifepristone is safe and effective and has been used by millions since FDA approval more than a quarter century ago. She stressed that the ruling restricts access in every state, including Washington, and puts women's lives and rights at risk.
Former Health and Human Services Secretary Xavier Becerra, now running for California governor, said the decision disproportionately affects vulnerable communities. He called it a dangerous step backward for reproductive freedom, arguing that blocking telehealth access will hit working families, rural communities, and those already facing barriers the hardest.
Democratic governors also weighed in. Gavin Newsom (Calif.) said access to mifepristone is critical for women in rural and underserved communities and vowed that California will continue to fight against those who seek to tear away a woman's right to choose. Gretchen Whitmer (Mich.) added that the ban is based on politics, not science.
Republican lawmakers praised the ruling. Senator James Lankford (R-Okla.) said the Biden administration endangered women and girls by removing safeguards, and that the Fifth Circuit decision takes a big step to right that wrong. Representative Chip Roy (R-Texas) called it great news for babies, adding that pills are the new battlefield for life.
The decision drew backlash from the American Civil Liberties Union and the Center for Reproductive Rights, which called it a devastating setback and warned it could further limit access to women's reproductive care. The ruling comes amid ongoing legal battles over abortion access, including a landmark Supreme Court ruling on racial gerrymandering and clashes between Trump and GOP with Democrats over Iran war powers.
